This document presents a summary of screening models used to evaluate antifertility drugs. It discusses several classes of antifertility drugs and their mechanisms of action, including GnRH antagonists, estrogen antagonists like clomiphene and aromatase inhibitors, and gonadotropins. It also describes in vivo and in vitro screening methods to assess effects on ovulation, implantation, and endometrial growth. Key in vivo tests include HCG-induced ovulation in rats, uterine weight assays in rabbits, and prevention of abortion in oxytocin-treated pregnant rabbits. Receptor binding assays and tests like the McGinty test are discussed as in vitro approaches.